Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.625 USD | +1.77% | +3.19% | -39.83% |
Financials (USD)
Sales 2024 * | 10.19M | Sales 2025 * | 8.11M | Capitalization | 881M |
---|---|---|---|---|---|
Net income 2024 * | -378M | Net income 2025 * | -403M | EV / Sales 2024 * | 69.2 x |
Net cash position 2024 * | 176M | Net cash position 2025 * | 137M | EV / Sales 2025 * | 91.8 x |
P/E ratio 2024 * |
-2.34
x | P/E ratio 2025 * |
-2.32
x | Employees | 309 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.64% |
Latest transcript on Relay Therapeutics, Inc.
1 day | +1.77% | ||
1 week | +3.19% | ||
Current month | +1.61% | ||
1 month | +8.43% | ||
3 months | -38.88% | ||
6 months | -23.14% | ||
Current year | -39.83% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjiv Patel
CEO | Chief Executive Officer | 50 | 17-02-28 |
Mark Murcko
FOU | Founder | 64 | 15-05-03 |
Alexis Borisy
FOU | Founder | 52 | 15-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Ingram
BRD | Director/Board Member | 61 | 19-05-31 |
Linda Hill
BRD | Director/Board Member | 67 | 18-10-08 |
Jami Rubin
BRD | Director/Board Member | 60 | 19-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 0 M€ | 0.00% | - | |
0.12% | 2 M€ | -.--% | ||
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 6.64 | +2.00% | 1,508,418 |
24-05-16 | 6.51 | -4.19% | 1,331,767 |
24-05-15 | 6.795 | +6.84% | 2,130,636 |
24-05-14 | 6.36 | -0.93% | 834,513 |
24-05-13 | 6.42 | 0.00% | 1,170,393 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.83% | 881M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- RLAY Stock